Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
12/2003
12/18/2003WO2003104467A1 Means and methods for the production of adenovirus vectors
12/18/2003WO2003104407A2 T cell receptor cdr3 sequences and methods for detection
12/18/2003WO2003104260A2 Pharmaceutical formulation
12/18/2003WO2003104253A2 9-alpha-substituted estratrienes as selectively active estrogen
12/18/2003WO2003104208A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104207A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104205A1 Aryloximes
12/18/2003WO2003104204A1 Pyridazine derivatives
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003103718A2 Intracellular delivery of biological effectors
12/18/2003WO2003103628A1 Device against diabetes (dicodia)
12/18/2003WO2003082817A3 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/18/2003WO2003079991A3 Method for administration of growth hormone via pulmonary delivery
12/18/2003WO2003074449A3 Multi-substitued selective androgen receptor modulators and methods of use thereof
12/18/2003WO2003059329A3 Polytartrate composition
12/18/2003WO2003050108A8 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
12/18/2003WO2003029437A3 Secreted proteins
12/18/2003WO2003022303A3 Use of hcg and lh in controlled ovarian hyperstimulation
12/18/2003WO2003000864A8 Nucleic acid-associated proteins
12/18/2003WO2002100899A3 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/18/2003WO2002038561A8 Indolylmaleimide derivatives as protein kinase c inhibitors
12/18/2003US20030232986 Inhibitors of caspases
12/18/2003US20030232859 Antiinflammatory agents; for treatment of rheumatoid arthritis and multiple sclerosis
12/18/2003US20030232846 Caspase inhibitors and uses thereof
12/18/2003US20030232837 17-Beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
12/18/2003US20030232824 Non-steroidal progesting
12/18/2003US20030232823 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof
12/18/2003US20030232795 Administering selective estrogen receptor modulators that possesses tissue-specific ER agonist activity
12/18/2003US20030232752 Proliferated cell lines and uses thereof
12/18/2003US20030232430 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
12/18/2003US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders
12/18/2003US20030232073 Enhanced drug delivery in transdermal systems
12/18/2003US20030232072 Pharmaceutical composition and method for treating hypogonadism
12/18/2003DE10215316C1 Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer Quinoline and isoquinoline derivatives, to a pharmaceutical agent and their use as anti-inflammatory agents
12/18/2003CA2488716A1 Intracellular delivery of biological effectors
12/18/2003CA2488403A1 Pharmaceutical formulation
12/18/2003CA2487924A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/18/2003CA2486491A1 4-(aryl or heteroaryl)-2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003CA2485874A1 T cell receptor cdr3 sequences and methods for detection
12/17/2003EP1370662A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370583A1 Polypeptides and nucleic acids for bolekine
12/17/2003EP1370281A2 Human growth hormone for treating children with abnormal short stature and kits and methods for diagnosing gs protein dysfunctions
12/17/2003EP1370279A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
12/17/2003EP1370277A1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis
12/17/2003EP1272470B1 Amorphous torasemide modification
12/17/2003EP1196148B1 Process for microencapsulation of water soluble substances
12/17/2003EP1007074B1 Hypothalamus-specific polypeptides
12/17/2003CN1462273A Bicyclic heteroaromatic compounds
12/17/2003CN1462195A Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same
12/17/2003CN1461754A Telerance starch made of starch of de-amylopectin by iso-anylase
12/17/2003CN1131235C 11'beta-halogen-7alpha-substd estratrienes, Preparation of Pharmaceutical preparation containing 11'beta'-halogen-7alpha-substd estratrienes
12/17/2003CN1131202C Calcium receptor-active compounds
12/16/2003US6664273 Having at least cyanobenzyl and amidobenzyl substituents; obesity, metabolic disorders, eating disorders such as hyperphagia and diabetes
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
12/16/2003CA2246289C New associations of active principles containing clopidogrel and an antithrombotic agent
12/11/2003WO2003102206A2 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003WO2003102188A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof
12/11/2003WO2003102012A2 New etonogestrel esters
12/11/2003WO2003101987A1 3-substituted quinuclidines and their use
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101970A1 Imidazolium cxcr3 inhibitors
12/11/2003WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003WO2003101927A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
12/11/2003WO2003101461A1 Norethindrone sustained release formulations and methods associated therewith
12/11/2003WO2003101376A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna)
12/11/2003WO2003101374A2 Use of new etonogestrel esters
12/11/2003WO2003092790A3 Methods for increasing the therapeutic response to electroconvulsive therapy ('ect')
12/11/2003WO2003080630A3 Phosphate transport inhibitors
12/11/2003WO2003048206A3 Growth hormone agonist peptides and their uses
12/11/2003WO2003027090A3 Bicyclic heterocycles as rxr ligands
12/11/2003WO2003026579A3 Combination therapies for immune mediated diseases
12/11/2003WO2002085925A3 Melanocortin receptor ligands
12/11/2003US20030229200 Useful in treating or preventing obesity
12/11/2003US20030229120 Zinc binding ligand; sustained release of insulin
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
12/11/2003US20030228653 Novel orphan cytokine receptor polypeptides
12/11/2003US20030228365 Pharmaceutical formulation
12/11/2003US20030228275 Immobilization of drugs
12/11/2003CA2487730A1 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003CA2487293A1 Use of new etonogestrel esters
12/11/2003CA2485111A1 Topical use of at least one double-stranded rna oligonucleotide (ds rna)
12/11/2003CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003CA2483834A1 Norethindrone sustained release formulations and methods associated therewith
12/11/2003CA2482639A1 3-substituted quinuclidines and their use
12/10/2003EP1369125A1 Treatment of partial growth hormone insensitivity syndrome
12/10/2003EP1369115A1 Methods of preventing breast cancer by the administration of Raloxifene
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368357A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds
12/10/2003EP1368349A1 Xanthine derivative, production and use thereof as a medicament
12/10/2003EP1368346A1 Substituted benzofuran-2-carboxamides derivatives
12/10/2003EP1368318A2 Calcilytic compounds
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
1 ... 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 ... 290